Results
1 -
10 of
26
(Click
here to explore results)
- Orphan Drugs and Rare Diseases, Chapter 12 Unleashing the Power of Semi-Synthesis: The Discovery of Torisel®. Jerauld S. Skotnicki, Magid A. Abou-Gharbia
, 2014
, Pages 347-366
- Smart Materials for Drug Delivery: Volume 2, CHAPTER 20 Multiple Stimuli-responsive Hydrogels Based on α-Amino Acid Residues for Drug Delivery. Mario Casolaro, Ilaria Casolaro
, 2013
, Volume 2
, Pages 199-227
- Nanomedicines: Design, Delivery and Detection, Chapter 8 Polymeric Nanoparticles and Cancer: Lessons Learnt from CRLX101. Ismael Gritli, Edward Garmey, Scott Eliasof, Andres Tellez, Mark E. Davis, Yen Yun
, 2016
, Pages 199-232
- Orphan Drugs and Rare Diseases, Subject Index
, 2014
, Pages 448-463
- Designing Multi-Target Drugs, Chapter 11 Combination Agents Versus Multi-Targeted Agents – Pros and Cons. Jose G. Monzon, Janet Dancey
, 2012
, Pages 155-180
- Accounts in Drug Discovery: Case Studies in Medicinal Chemistry, Chapter 14 Uncoupling Neuroprotection from Immunosuppression: the Discovery of ILS-920. Edmund I. Graziani
, 2011
, Pages 316-331
- Orphan Drugs and Rare Diseases, Contents
, 2014
, Pages P013-P022
- Natural Product Chemistry for Drug Discovery, Chapter 11 A Snapshot of Natural Product-Derived Compounds in Late Stage Clinical Development at the End of 2008. Mark S. Butler
, 2009
, Pages 321-354
- Macrocycles in Drug Discovery, CHAPTER 1 Bioactive Macrocycles from Nature. David J. Newman, Gordon M. Cragg
, 2015
, Pages 1-36
- Kinase Drug Discovery, Chapter 5 Kinase Mutations and Resistance in Cancer. Jack Andrew Bikker
, 2012
, Pages 126-160